期刊文献+

原发性巨球蛋白血症14例临床分析 被引量:1

Clinical analysis of 14 patients with Waldenstrm Macroglobulinemia
下载PDF
导出
摘要 目的探讨原发性巨球蛋白血症(WM)的临床特点。方法对14例WM患者进行回顾性分析。结果11例接受治疗的患者完全缓解3例,部分缓解4例。7例存活,病程最长达10.5年。结论WM是不能治愈性疾病,但经积极治疗生存期可延长。WM伴有血粘滞性增高者预后不佳,化疗及血浆分离术后可获长期生存。 ObjectiveTo investigate the diagnosis and treatment of Waldenstrm Macroglobulinemia. MethodsThe clinicalinformation of 14 patients with Waldenstrm Macroglobulinemia were analyzed retrospectively. Results3 cases had achievedcomplete response(CR). 4 cases had achieved partial response(PR). 7 cases remained alive with event-free survival, one of thembeyonded 10.5 years. Conclusions The feasibility of the combination agent appears highly active and safe in the management ofWM.
出处 《罕少疾病杂志》 2002年第5期4-5,共2页 Journal of Rare and Uncommon Diseases
关键词 原发性巨球蛋白血症 高粘滞综合征 诊断 治疗 临床分析 Waldenstrm Macroglobulinemia hyperviscosity syndrome
  • 相关文献

参考文献7

  • 1Ahmed S, Shurafa MS, Bishop CR, et al. Waldenstrom's macroglobulinemia in young African-American adults[J].Am J Hematol, 1999,60(3):229~230.
  • 2Wang JF, Schroder JM. Morphometric evaluation of paraneoplastic neuropathies associated with carcinomas, lymphomas, and dysproteinemias[J]. J Peripher Nerv Syst, 1998,3(4): 259~266.
  • 3Pangalis GA, Angelopoulou MK, Vassilakopoulos TP, et al. B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma,including Waldenstrom's macroglobulinemia: a clinical,morphologic, and biologic spectrum of similar disorders[J]. Semin Hematol,1999, 36(2): 104~ 114.
  • 4Foran JM, Rohatiner AZ, Coiffier B, et al. Multicenter phase Ⅱ study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma,Waldenstrom's macroglobulinemia, and mantle-cell lymphoma[J]. J Clin Oncol, 1999, 17(2):546~553.
  • 5Laurencet FM, Zulian GB, Guetty-Alberto M, et al. Cladribine with cyclophosphamide and prednisone in the management of lowgrade lymphoproliferative malignancies[J]. Br J Cancer, 1999,79(7 ~ 8): 1215 ~ 1219.
  • 6Behr TM, Wormann B, Gramatzki M, et al. Low-versus high-dose radioimmunotherapy with humanized antiCD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies[J]. Clin Cancer Res, 1999,5 (10suppl): 3304~3314.
  • 7Martino R, Shah A, Romero P, et al. Allogeneic bone marrow transplantation for advanced Waldenstrom ' s macroglobulinemia[J]. Bone Marrow Transplant, 1999, 23(7): 747~749.

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部